Skip to Main Content

Podcast Archive

HelixTalk #151 - Deep Dive into Diltiazem: Pharmaceutics, Medicinal Chemistry, the FDA Orange Book, and More!

Date posted: July 26, 2022, 6:00 am

In this episode, we “deep dive” into diltiazem, describing its most important drug facts, pharmacology and medicinal chemistry, pharmaceutics, AB compatibility, and important medication safety issues.

HelixTalk #150 - Keep on Going Strong: A Reflection of 150 HelixTalk Episodes Through the Years

Date posted: July 5, 2022, 6:00 am

In this episode, the hosts of the HelixTalk reflect back on the history and making of HelixTalk to commemorate the 150th episode. We review each of our three favorite episodes and with a brief reflection on the episode content. We have come a long way from where we began and it is all thanks to the wonderful listeners and contributors who have a common thing in mind: a quest and thirst for knowledge!

HelixTalk #149 - Replenishing the Missing Element: A Complete Review of Iron Deficiency Anemia

Date posted: June 14, 2022, 6:00 am

In this episode, we will cover a complete overview of definition, diagnosis, treatment and monitoring of iron deficiency anemia (IDA).

HelixTalk #148 - Grit, Determination, and Entrepreneurship: A Pharmacist’s Career Path to Starting an Independent Pharmacy

Date posted: May 24, 2022, 6:00 am

In this episode, we interview Hetal Patel, PharmD and RFUMS COP alumnus, regarding her career path that eventually led her to open Lebanon Family Pharmacy in TN in 2021. We discuss the challenges and opportunities of starting a new independent pharmacy and what the future of independent pharmacy looks like.

HelixTalk #147 - Key Recommendations from the 2022 AHA/ACC/HFSA Heart Failure Guidelines

Date posted: May 3, 2022, 6:00 am

In this episode, we review new updates and key concepts from the 2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure. This guideline is newly published (April 2022) and is a full update of the 2013 guidelines and the 2017 focused update for heart failure.

HelixTalk #146 - New Drugs for Bad Bugs: Six Newer Antibiotics for Multidrug Resistant Pathogens

Date posted: April 12, 2022, 6:00 am

In this episode, we discuss six newer antibiotics that target multidrug resistant gram negative bacteria with Dr. Christie Bertram, PharmD, BCIDP. We review common resistance mechanisms, particularly to carbapenems, and highlight the current role in therapy for the following antibiotics: ceftolozane/tazobactam (Zerbaxa®), ceftazidime/avibactam (Avycaz®), meropenem/vaborbactam (Vabomere®), imipenem/cilastatin/relebactam (Recarbrio®), cefiderocol (Fetroja®), and eravacycline (Xerava®).

HelixTalk #145 - Advancing the Profession: Contraceptive Prescribing by Pharmacists in Illinois

Date posted: March 22, 2022, 6:00 am

In this episode, we bring in two guests to discuss the impact of professional advocacy and resulting professional advancements in the state of Illinois. These guests were the front-line agents of advocacy which resulted in pharmacists' ability to prescribe hormonal contraceptives for patients in Illinois (HB 135). We take a deep dive into their efforts to make this change possible, how it will impact patient care, and its implications on possibilities for further advancement of the pharmacy profession all the while highlighting the importance of professional advocacy.

HelixTalk #144 - mRNA Technologies and their Implications in Therapeutics: Q&A with Dr. Martin

Date posted: March 1, 2022, 6:00 am

In this episode, we interview Dr. Danyelle Martin, a Medical Science Liaison (MSL) at Moderna, in order to learn more about the what, how, and future of mRNA-based therapeutics, and what impact it can have on healthcare and healthcare professionals in general.

HelixTalk #143 - The Low Down on Hypothyroidism: The Essentials of What Healthcare Providers Need to Know

Date posted: February 8, 2022, 6:00 am

In this episode, we review the diagnostic criteria and treatment strategy of hypothyroidism including the controversy surrounding brand versus generic levothyroxine and non-levothyroxine thyroid drugs.

HelixTalk #142 - New Gains in Weight Loss Pharmacotherapy

Date posted: January 18, 2022, 6:00 am

In this episode, we will build up on our previous Weight loss Pharmacotherapy Episode, episode #13 to discuss updates in guidelines, prevention of obesity from comorbidity standpoint, and new treatment agents for weight-loss with a particular focus on Contrave (naltrexone/bupropion), Saxenda (liraglutide), and Wegovy (semaglutide).